Literature DB >> 2562959

Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.

H G Eichler1, G A Ford, T F Blaschke, A Swislocki, B B Hoffman.   

Abstract

Patients with essential hypertension show an increase in vascular resistance. It is unclear whether this is caused by structural changes in the arterial wall or by hyperresponsiveness of vascular smooth muscle to endogenous alpha adrenergic agonists. Using the dorsal hand vein compliance technique we compared the changes in diameter of superficial veins in response to phenylephrine, an alpha 1 adrenergic receptor agonist, and to nitroglycerin, a venorelaxant, in patients with essential hypertension and in normotensive subjects. The dose of phenylephrine that produced 50% of maximal venoconstriction (ED50) in the hypertensive subjects was 257 ng/min (geometric mean; log mean +/- SD was 2.41 +/- 0.54). In the control subjects the ED50 was 269 ng/min (geometric mean; log mean was 2.43 +/- 0.43). Maximal response (Emax) for phenylephrine was 84 +/- 13% in the hypertensive subjects and 90 +/- 6% in the control subjects. Differences in the group means of the ED50 (P = 0.92) or the Emax (P = 0.27) were not significant. There were no significant differences in the ED50 (P = 0.54) or the Emax (P = 0.08) for nitroglycerin between the two groups. These results show no evidence for a generalized change in alpha adrenergic responsiveness in hypertension and support the concept that increased blood pressure responses to alpha adrenergic stimulation in hypertensives are due to structural and geometric changes in the arterial wall rather than to an increased responsiveness of postsynaptic alpha adrenergic receptors. The phenylephrine studies were repeated in seven hypertensive patients during treatment with prazosin, an alpha 1 adrenergic antagonist. The mean dose ratio of the shift in phenylephrine ED50 (ED50 during prazosin therapy/ED50 before prazosin therapy) was 6.1. This indicates that small doses of prazosin (1-2 mg) cause significant in vivo shifts in the dose-response relationship of alpha adrenergic agonists. The dorsal hand vein compliance technique is useful in detecting systemic effects of alpha adrenergic antagonists.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562959      PMCID: PMC303650          DOI: 10.1172/JCI113845

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension.

Authors:  B Folkow
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

2.  Blood pressure response to norepinephrine infusion in relationship to plasma catecholamines and renin activity in man.

Authors:  N D Vlachakis
Journal:  J Clin Pharmacol       Date:  1979-10       Impact factor: 3.126

3.  Uneven distribution of postjunctional alpha 1-and alpha 2-like adrenoceptors in canine arterial and venous smooth muscle.

Authors:  J De Mey; P M Vanhoutte
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

Review 4.  Regulation of alpha and beta adrenergic receptors in man.

Authors:  B B Hoffman
Journal:  Clin Endocrinol Metab       Date:  1983-03

Review 5.  Physiological aspects of primary hypertension.

Authors:  B Folkow
Journal:  Physiol Rev       Date:  1982-04       Impact factor: 37.312

6.  A new technique for recording compliance of human hand veins.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

7.  Norepinephrine clearance and pressor effect in normal and hypertensive man.

Authors:  M Grimm; P Weidmann; G Keusch; A Meier; Z Glück
Journal:  Klin Wochenschr       Date:  1980-11-03

8.  Effect of age on the responsiveness of vascular alpha-adrenoceptors in man.

Authors:  H L Elliott; D J Sumner; K McLean; J L Reid
Journal:  J Cardiovasc Pharmacol       Date:  1982 May-Jun       Impact factor: 3.105

9.  Prazosin dynamics in hypertension: relationship to plasma concentration.

Authors:  P Seideman; A Grahnén; K Haglund; B Lindström; C von Bahr
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

10.  Agonist versus antagonist binding to alpha-adrenergic receptors.

Authors:  B B Hoffman; T Michel; D M Kilpatrick; R J Lefkowitz; M E Tolbert; H Gilman; J N Fain
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more
  17 in total

1.  Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline.

Authors:  A H Abdelmawla; R W Langley; E Szabadi; C M Bradshaw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.

Authors:  Tetsuro Matsunaga; Koichiro Yasuda; Tetsuya Adachi; Ning Gu; Tsubasa Yamamura; Toshio Moritani; Gozoh Tsujimoto; Kinsuke Tsuda
Journal:  J Hum Genet       Date:  2006-10-31       Impact factor: 3.172

3.  In vivo studies on alpha-adrenergic receptor subtypes in human veins.

Authors:  B Blöchl-Daum; A Korn; M Wolzt; E Schmidt; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

4.  Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

Authors:  C M Stein; R Nelson; R Deegan; H He; M Wood; A J Wood
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 5.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

Review 6.  Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.

Authors:  R D Feldman
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

7.  Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans.

Authors:  J Vincent; W Dachman; T F Blaschke; B B Hoffman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.

Authors:  M Wolzt; W Gerschlager; B Zweytick; B Jilma; H Riemer; K Sertl; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

9.  Effects of serotonin and noradrenaline on superficial hand veins in patients with primary hypertension and in healthy volunteers.

Authors:  M Wolzt; E Schmidt; B Wagner; S Schuller-Petrovic; P A Kyrle; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

10.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

Authors:  W G Haynes; M F Hand; H A Johnstone; P L Padfield; D J Webb
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.